Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
 
(112 intermediate revisions by 9 users not shown)
Line 1: Line 1:
ALK positive large B cell lymphomaALK positive large B cell lymphomaWelcome!
Welcome!  


*For assignments, please see the "Author" column below.  If no name is present, volunteer to create content!
*We will be creating content for all entities with genetic findings in the current WHO Classification of Tumours books.  '''<u>If there is an entity not yet listed below that you would like to author in any WHO book, we would be happy to create a page for you now</u>'''.
*To volunteer, please '''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your page of interest.
__TOC__


==WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content==
We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books.  Please join the effort!  
{| class="wikitable"
 
|-
 
!'''Disease'''!!'''Page Type'''!!'''Author'''
To volunteer:  
!'''Date Assigned to Author'''
 
!'''Target Completion Date'''
#Select a link in the table to your book(s) of interest to view specific authorship opportunities.  Additional books are in the process of being added.
!'''Author Content (Pending or Complete)'''
#'''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your disease page of interest.  You will be connected with an Associate Editor to help guide you through the process.
!'''Date Completed by Author'''!!'''Associate Editor'''
#Complete the brief '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]''' to receive your log-in credentials.  Information on [[Description of CCGA Roles|<u>Authorship and Other Roles</u>]] with the CCGA is available.
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|complete
|
|Fabiola Quintero-Rivera (FQR)
|Date page was created
|
|-
|    Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive||Disease
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|Date page was created
|
|-
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|Date page was created
|
|-
|    Polycythaemia Vera  (PV)||Disease
|Gokce A. Toruner
|
|
|complete
|
|FQR
|
|
|-
|    Primary Myelofibrosis (PMF)||Disease
|T. Niroshi  Senaratne
|
|
|complete
|
|FQR
|8/4/2020 before submission
|
|-
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith
|
|
|complete
|
|FQR
|
|8/1/21 FQR deleted "'''This page is under construction'''
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|Chelsea D. Kramish (trainee), Daynna J.Wolff
|
|
|complete/pending faculty review
|
|FQR
|
|
|-
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Thomas Lee
|
|
|complete
|
|FQR
|
|
|-
|'''''Mastocytosis'''''||'''''Overview'''''||Shashi Shetty, Ph.D.
|
|
|complete
| ||FQR
|
|
|-
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung + Shuo-Shawn Liu (trainee)
|
|
|complete
|
|FQR
|
|8/1/21 FQR deleted "'''This page is under construction'''
|-
|    Systemic Mastocytosis||Disease
|Shashi Shetty
|
|
|complete
|
|FQR
|
|
|-
|    Mast Cell Sarcoma||Disease
|Thuy Phung +Jordan Lowery (trainee)
|
|
|complete
|
|FQR
|
|
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|
|
|complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Disease
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
|
|
|Complete
|
|FQR
|
|NON-WHO ENTITY
|-
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Disease
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
|
|
|Complete
|
|FQR
|
|NON-WHO ENTITY
|-
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|9/1/20
|PENDING importing content and reference formatting
|
|FQR
|
|FQR has emailed SR several times, last 4/20/22
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|Date page was created
|
|-
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|
|
|complete
|
|FQR
|
|
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|4/21/22
|pending
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|complete
|
|FQR
|
|
|-
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|Complete
|
|FQR
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|
|
|Complete
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|04/26/2021 -MS (re-review)
|
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|
|
|''<s>PENDING</s> Complete - awaiting clarification''
| ||JH / MS
|04/26/2021 -MS (re-review)
|Review completed, awaiting some clarification from JH - 07/04/2022
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|03/01/2021-MS
|
|-
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
|
|
|Complete
|02/03/2021||JH / MS
|
|
|-
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|03/02/2021-MS
|
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
|
|
|Complete
| ||JH / MS
|03/02/2021-MS (re-review)
|
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|
|
|Complete
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|-
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|
|
|Complete
|
|JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
|04/26/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|02/24/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|
|
|Complete
| ||JH / MS
|
|Need permission for figure?  Update WHO?
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg
Corboy (Monash Health)
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu
|
|
|Complete
| ||JH / MS
|
|Add WHO reference
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Corboy (Monash Health)
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|
|
|Complete
| ||JH / MS
|
|
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|
|
|Complete
| ||JH / MS
|
|Check reference format
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|
|
|Complete
| ||JH / MS
|
|
|-
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|
|
|Complete
| ||JH / MS
|
|
|-
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
|
|
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|
|
|Complete
| ||JH / MS
|
|Need permission for figure?
|-
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
|
|
|-
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
|
|
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|
|
|Complete
| ||JH / MS
|
|
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|
|
|Complete
| ||JH / MS
|
|Check reference format
|-
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|
|
|Complete
| ||JH / MS
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
|
|
|-
|    Mixed-Phenotype Acute Leukemia, Not  Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|
|
|PENDING
| ||JH / MS
|
|
|-
|    Acute Leukemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|
|
|PENDING
| ||JH / MS
|
|
|-
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Kay Weng Choy + Greg Corboy (Monash Health)
|
|
|Complete
|
|JH / MS
|
|NON-WHO ENTITY
|-
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|Disease
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|PENDING
|
|JH / MS
|
|NON-WHO ENTITY
|-
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
|Disease
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|PENDING
|
|JH / MS
|
|NON-WHO ENTITY
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Yassmine Akkari (YA)
|
|
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|
|
|
| ||YA
|
|
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain (trainee) + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|
|
|PENDING
|
|YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +


Lisa Smith + Yassmine Akkari
|
|
|Complete
|
|YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|
|
|PENDING
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|
|
|PENDING
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|
|
|Complete
|
|YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
|
|
|Complete
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|
|
|PENDING
| ||YA
|
|
|-
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Celeste Eno
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Chenkai Ma
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|PENDING
| ||YA
|
|
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|2021 template added
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|2021 template added
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|SP
|
|
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||
|
|
|
|
|SP
|
|2021 template added
|-
|B-cell Prolymphocytic Leukemia||Disease||Zejuan Li
|4/28/22
|
|PENDING
|
|SP
|
|2021 template added
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|Lymphoplasmacytic Lymphoma||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
|
|
|PENDING
|
|SP
|
|2021 template added
|-
|   Waldenstrom  Macroglobulinemia||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
|
|
|PENDING
|
|SP
|
|2021 template added
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|    Mu Heavy Chain  Disease||Disease||
|
|
|
| ||SP
|
|
|-
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|
|
|Complete
|5/26/2021||SP
|
|
|-
|    Alpha Heavy Chain  Disease||Disease||
|
|
|
| ||SP
|
|
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|PENDING
|
|SP
|
|
|-
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||Chen Yang, MD, PhD
|
|
|Complete
|09/10/2022||SP
|
|
|-
|           Primary  Amyloidosis||Disease||Heather E. Williams, PhD
|
|
|?PENDING
| ||SP
|
|
|-
|           Light Chain  and Heavy Chain Deposition Disease||Disease||Chen Yang, MD, PhD
|
|
|?PENDING
| ||SP
|
|
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||Sohini Anand
|8/31/2021
|9/15/2021
|PENDING
| ||SP
|
|
|-
|         POEMS Syndrome||Disease||Sohini Anand, MBBS, and Tharanga Niroshini Senaratne, PhD
|
|
|?PENDING
| ||SP
|
|
|-
|         TEMPI Syndrome||Disease||Sohini Anand, MBBS
|
|
|?PENDING
| ||SP
|
|
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee (trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|PENDING
|
|SP
|
|2021 template added
|-
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|Complete
|5/28/2021||SP
|
|
|-
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|11/11/2020
|SP
|
|
|-
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|-
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|-
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|-
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|8/16/2020
|SP
|
|
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|9/30/20
|Complete
|5/26/2021||SP
|
|
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|Complete
|09/10/2022
|SP
|
|
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|8/15/20
|PENDING
|
|SP
|
|
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari, MD
|
|
|?PENDING
|
|SP
|
|
|-
|    In Situ Mantle Cell  Neoplasia||Disease||Rina Kansal, MD
|6/12/22
|
|Complete
|7/26/2022
|SP
|
|2021 template added
|-
| || ||
|
|
|
| ||
|
|
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|PENDING
|
|Greg Corboy (GC)
|
|Requested to update 14022022
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||Laveniya Satgunaseelan
|26/10/2021
|26/1/2022
|Complete
|03/28/22||GC
|03/28/22
|2021 template added
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
| ||GC
|
|
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|-
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
| ||GC
|
|
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|
|
|
| ||GC
|
|
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Lymphomatoid Granulomatosis||Disease||
|
|
|
| ||GC
|
|
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Intravascular Large B-cell Lymphoma||Disease||Kate Berry, Greg Corboy
|25/01/2022
|25/4/2022
|Complete
|9/1/22||GC
|9/1/22
|Emailed 28/3/2022 for progress update
|-
|ALK-Positive Large B-cell Lymphoma||Disease||Nakasaki Manando
|
|
|PENDING
| ||GC
|
|Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note).  2021 template added.
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|Complete
| ||GC
|28/03/2022
|
|-
|Primary Effusion Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|   Multicentric Castleman  Disease||Disease||Sudha Arumugam
|10/26/2021
|1/26/2022
|Complete
|24/01/2022||GC
|24/01/2022
|2021 template added
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Xiao Zhou, MD, PhD, Siparadigm
|10/26/2021
|1/26/2022
|PENDING
| ||GC
|
|Emailed 28/3/2022 for progress update
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||Xiao Zhou, MD, PhD, Siparadigm
|10/26/2021
|1/26/2022
|PENDING
| ||GC
|
|Emailed 28/3/2022 for progress update
|-
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|06/28/2021
|Complete
|28/06/2021||GC
|28/06/2021
|
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||Lauren Shealy (trainee), Daynna Wolff
|10/13/21
|01/13/2022
|Complete
|27/01/2022
|GC
|27/01/2021
|2021 template added
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||Kate Berry, Greg Corboy
|30/05/21
|30/08/21
|Complete
|24/02/2022||GC
|24/02/2022
|
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Aiko Otsubo, Holli Drendel
|7/30/21
|10/30/21
|Complete
|15/11/2021
|GC
|16/11/2021
|
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|-
|Aggressive NK-cell Leukemia||Disease||Shanelle De Lancy, MD, Shashirekha Shetty, PhD
|
|
|?PENDING
| ||SP
|
|
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|Complete
|11/21/2021||SP
|
|
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
| ||SP
|
|
|-
|    Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
| ||SP
|
|
|-
|    Severe Mosquito Bite  Allergy||Disease||
|
|
|
| ||SP
|
|
|-
|Adult T-cell Leukemia/Lymphoma||Disease||Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG
|
|
|?PENDING
| ||SP
|
|
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|Complete
|1/21/2021
|SP
|
|
|-
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|Complete
|1/21/2021
|SP
|
|
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|PENDING
| ||SP
|
|
|-
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee), Tingting Barrett (trainee)
|
|
|PENDING
| ||SP
|
|
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|    Lymphomatoid  Papulosis||Disease||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD
|
|
|PENDING
| ||SP
|
|
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|PENDING
| ||SP
|
|
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
| ||Greg Corboy (GC)
|
|
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||Thomas Harrington (resident) + Daynna Wolff
|06/22/2022
|09/22/2022
|PENDING
| ||GC
|
|2021 template added, Daynna organising
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||Xiaolin (Lynn) Hu
|
|
|Completed
|03/21/22||GC
|03/21/22
|Edits sent 14022022
|-
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|
|
|PENDING
| ||GC
|
|2021 template added
|-
|    Mixed Cellularity Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|
|
|PENDING
| ||GC
|
|2021 template added
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|
|
|PENDING
| ||GC
|
|2021 template added
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Lymphomas Associated with HIV Infection||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|11/2/21
|02/02/22
|Completed
|03/21/22
|GC
|03/21/22
|2021 template added
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Ania Shestakova (trainee) + Fabiola Quintero-Rivera
|
|
|completed
|april 2022
|GC
|26/4/2022
|
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Histiocytic Sarcoma||Disease||Marie-France Gagnon, MD, Mayo Clinic (LGG fellow trainee), Xinjie Xu, PhD FACMG, Mayo Clinic
|
|
|Complete
|10/01/2021
|GC
|10/01/2021
|Xinjie Xu
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|   Langerhans Cell  Histiocytosis||Disease||Malaika Perchard, Greg Corboy
|02/01/2022
|05/01/2022
|Complete
|04/28/2022||GC
|5/19/2022
|
|-
|   Langerhans Cell  Sarcoma||Disease||Malaika Perchard, Greg Corboy
|02/01/2022
|05/01/2022
|Complete
|04/28/2022||GC
|5/19/2022
|
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
| ||GC
|
|
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|-
|Erdheim-Chester Disease||Disease||Prashant Deshpande
|02/02/2022
|05/02/2022
|PENDING
| ||GC
|
|emailed 28/3/2022 to get update
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|}<br />


==WHO Classification of Tumours of the Central Nervous System Content==
{| class="wikitable"
{| class="wikitable"
|+BOOKS WITH CONTENT IN PROGRESS
!Book Name
!Book Edition
!Book Acronym
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
|[[HAEM5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues]]
!'''Date Assigned to Author'''
|5th
!'''Target Completion Date'''
|HAEM5
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Medulloblastoma, WNT-activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|[[CNS5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Central Nervous System]]
|9/20/21
|5th
|
|CNS5
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|-
|Paediatric-Type Diffuse High-Grade Gliomas
|[[GTS5:Volunteer Assignments and Opportunities|WHO Classification of Genetic Tumour Syndromes]]
|Overview
|5th
|
|GTS5
|
|
|
|
|
|
|2021 template added
|-
|-
|Diffuse Midline Glioma, H3 K27-Altered
|[[BRST5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Breast]]
|Disease
|5th
|Laveniya Satgunaseelan (Linda Cooley - previous version)
|BRST5
|
|
|PENDING
|
|Laveniya Satgunaseelan (LS)
|
|2021 template added
|-
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant
|[[STBT5:Volunteer Assignments and Opportunities|WHO Classification of Soft Tissue and Bone Tumours]]
|Disease
|5th
|Xiaolin (Lynn) Hu
|STBT5
|2/21/2022
|}
|
 
|PENDING
|
|LS
|
|2021 template added
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype
|Disease
|
|
|
|
|
|
|
|2021 template added
|-
|Infant-Type Hemispheric Glioma
|Disease
|
|
|
|
|
|
|
|2021 template added
|-
|Astrocytoma, IDH-Mutant
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|3/3/2022
|
|PENDING
|
|LS
|
|2021 template added
|-
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|3/3/2022
|
|PENDING
|
|LS
|
|2021 template added
|-
|Ganglioglioma
|Disease
|Leila Moayed-Aloei
|6/30/2022
|
|PENDING
|
|LS
|
|
|-
|Pilocytic astrocytoma
|Disease
|Jeremy Pulvers
|9/13/2022
|
|PENDING
|
|LS
|
|
|-
|}<br />


==WHO Classification of Soft Tissue and Bone Tumours Content==
{| class="wikitable"
{| class="wikitable"
|+BOOKS COMING SOON
!Book Name
!Book Edition
!Book Acronym
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
|[[DIG5:Volunteer Assignments and Opportunities|WHO Classification of Digestive System Tumours]]
!'''Date Assigned to Author'''
|5th
!'''Target Completion Date'''
|DIG5
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
|2/20/2022
|
|PENDING
|
|Alanna Church
|
|
|-
|}<br />
 
==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
{| class="wikitable sortable"
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|BCR
|Brian Davis
|
|
|Complete
|8/10/18
|
|
|
|-
|ABL1
|Brian Davis
|
|
|Complete
|4/16/19
|
|
|
|-
|RUNX1
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|RUNX1T1
|Brian Davis
|
|
|Complete
|5/23/19
|
|
|
|-
|MYH11
|Brian Davis
|
|
|Complete
|8/6/18
|
|
|
|-
|FLT3
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|NPM1
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|TP53
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|DNMT3A
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|CEBPA
|Gordana
|
|
|Complete
|
|
|
|
|-
|IDH1
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|IDH2
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|PML
|Brian Davis
|
|
|Complete
|12/5/18
|
|
|
|-
|RARA
|Brian Davis
|
|
|Complete
|8/3/18
|
|
|
|-
|ETV6
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|KIT
|Brian Davis
|
|
|Complete
|10/1/18
|
|
|
|-
|CBFB
|Brian Davis
|
|
|Complete
|8/2/18
|
|
|
|-
|GATA2
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|PTEN
|Beth Pitel
|
|
|Pending
|
|
|
|
|-
|MLTT3
|
|
|
|
|
|
|
|
|-
|MECOM
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|FGFR1(FLT2)
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|KMT2A
|
|
|
|
|
|
|
|
|-
|DEK
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|-
|NUP214
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|-
|RBM15
|
|
|
|
|
|
|
|
|-
|MKL1
|
|
|
|
|
|
|
|
|-
|DDX41
|Ying Zou
|8/7/20
|
|Pending
|
|
|
|
|-
|ANKRD26
|
|
|
|
|
|
|
|
|-
|CUX1
|
|
|
|
|
|
|
|
|-
|TET2
|
|
|
|
|
|
|
|
|-
|EZH2
|
|
|
|
|
|
|
|
|-
|FOXP1
|
|
|
|
|
|
|
|
|-
|MYC
|
|
|
|
|
|
|
|
|-
|JAK2
|
|
|
|
|
|
|
|
|-
|WT1
|DONE
|
|
|DONE
|
|
|
|
|-
|CBL
|
|
|
|
|
|
|
|
|-
|NF1
|
|
|
|
|
|
|
|
|-
|SUZ12
|
|
|
|
|
|
|
|
|-
|ERG
|
|
|
|
|
|
|
|
|-
|EST2
|
|
|
|
|
|
|
|
|-
|RPS14
|
|
|
|
|
|
|
|
|-
|RB1
|
|
|
|
|
|
|
|
|-
|MPL
|
|
|
|
|
|
|
|
|-
|CHGA
|
|
|
|
|
|
|
|
|-
|CDH1
|
|
|
|
|
|
|
|
|-
|SRSF2
|
|
|
|
|
|
|
|
|-
|DNMT1
|
|
|
|
|
|
|
|
|-
|PRDX2
|
|
|
|
|
|
|
|
|-
|ASXL1
|DONE
|
|
|DONE
|
|
|
|
|-
|-
|MN1
|[[EYE5:Volunteer Assignments and Opportunities|WHO Classification of Eye and Orbit Tumours]]
|
|5th
|
|EYE5
|
|
|
|
|
|
|-
|-
|SF3A1
|[[SKIN5:Volunteer Assignments and Opportunities|WHO Classification of Skin Tumours]]
|
|5th
|
|SKIN5
|
|
|
|
|
|
|-
|-
|EP300
|[[HAN5:Volunteer Assignments and Opportunities|WHO Classification of Head and Neck Tumours]]
|
|5th
|
|HAN5
|
|
|
|
|
|
|-
|-
|JARID2
|[[ENDO5:Volunteer Assignments and Opportunities|WHO Classification of Endocrine and Neuroendocrine Tumours]]
|
|5th
|
|ENDO5
|
|
|
|
|
|
|-
|-
|BRCA1
|[[MALE5:Volunteer Assignments and Opportunities|WHO Classification of Urinary and Male Genital Tumours]]
|
|5th
|
|MALE5
|
|
|
|
|
|
|-
|-
|BRCA2
|[[PEDS5:Volunteer Assignments and Opportunities|WHO Classification of Paediatric Tumours]]
|
|5th
|
|PEDS5
|
|
|
|
|
|
|-
|-
|
|[[THOR5:Volunteer Assignments and Opportunities|WHO Classification of Thoracic Tumours]]
|
|5th
|
|THOR5
|
|
|
|
|
|
|-
|-
|
|[[FEMA5:Volunteer Assignments and Opportunities|WHO Classification of Female Genital Tumours]]
|
|5th
|
|FEMA5
|
|
|
|
|
|
|}
|}
Retrieved from "https://test.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"